Hjem › Prostatakræft › Nebraska › Omaha
Prostatakræft kliniske forsøg i Omaha, NE
27 studier for Prostatakræft søger deltagere på steder i og omkring Omaha (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mi væk
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
RekruttererFase 1/2
- Urology Cancer Center, PC, Omaha
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RekruttererFase 3
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026), Omaha
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
RekruttererFase 2/3
- Nebraska Cancer Specialists, Omaha
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
RekruttererFase 3
- Nebraska Cancer Specialists, Omaha
PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
RekruttererFase 2
- University of Nebraska Medical Center, Omaha
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
RekruttererFase 1
- XCancer, Omaha
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
RekruttererFase 3
- XCancer Omaha LLC, Omaha
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RekruttererFase 3
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mi væk
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
RekruttererFase 1/2
- Research Site, Omaha
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
RekruttererFase 3
- Research Site, Omaha
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
RekruttererFase 2
- XCancer Omaha, Omaha
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
RekruttererFase 1/2
- Nebraska Cancer Specialists, Omaha
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RekruttererFase 3
- Alegent Health Bergan Mercy Medical Center, Omaha
Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
RekruttererFase 2
- University of Nebraska Medical Center, Omaha
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RekruttererFase 3
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Integrated Cancer Repository for Cancer Research
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- og 1 flere
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
RekruttererFase 1
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
- XCancer Omaha / Urology Cancer Center, Omaha
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
RekruttererFase 4
- Urology Cancer Center PC, Omaha
- Nebraska Cancer Specialists, Omaha
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
RekruttererFase 1/2
- XCancer Omaha / Urology Cancer Center, Omaha
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
RekruttererFase 1
- Research Site, Omaha
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
RekruttererFase 2
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
- og 3 flere
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
RekruttererFase 3
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mi væk
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer
Rekrutterer
- University of Nebraska Medical Center, Omaha
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservationsstudie
- Massive Bio SYNERGY-AI site, Omaha
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RekruttererFase 3
- Nebraska Methodist Hospital, Omaha
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- og 1 flere
Prostatakræft forsøg i andre byer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN42 studier
- Seattle, WA42 studier
- Washington, DC38 studier
Andre studier i Omaha
- Ikke-småcellet lungecancer24 studier
- Brystkræft22 studier
- Colorektal kræft18 studier
- Kræft (alle typer)18 studier
- Multipelt myelom16 studier
- Non-Hodgkin lymfom14 studier
- Ægstockræft14 studier
- Bugspytkirtelkræft14 studier
- Pladecellekræft i hoved og hals13 studier
- Hjertesvigt13 studier
- Metastatisk cancer13 studier
- Nyrekancer (renocellulært karcinom)12 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.